Table 2a Comparison between the different studied groups of liver fibrosis according to demographic parameters.

From: Validation of albumin platelet product as a non-invasive fibrosis staging tool in patients with chronic HCV-related liver disease

 

Liver biopsy

Test of Sig.

p

Mean ± SD.

F0 – F1 (n = 244)

F2 (n = 104)

F3 (n = 102)

F4 (n = 130)

Age (years)

33.5 ± 8.85

35.3 ± 8.14

39.8 ± 7.67

46.5 ± 6.96

F = 61.603*

< 0.001*

Male Sex

188 (77.1%)

75 (71.6%)

77 (75.0%)

91 (70.0%)

χ2 = 2.147

0.542

BMI (kg/m2)

26.5 ± 2.88

26 ± 2.86

26.9 ± 2.82

27.7 ± 1.81

H = 19.445*

< 0.001*

  1. BMI, body mass indexSD: Standard deviation, χ2: Chi-square test, F: F for One way ANOVA test, Pairwise comparison bet. each 2 groups were done using Post Hoc Test (Tukey), H: H for Kruskal Wallis test, and Pairwise comparison bet. each 2 groups were done using a Post Hoc Test (Dunn’s for multiple comparisons test), p: p-value for comparing between the different studied groups *: Statistically significant at p ≤ 0.05.
Back to article page